← Ishga qaytish
Ushbu ishga iqtibos qilgan ishlar
2 ta ish
Ish: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Kashfiyot
Xizmatlar
Ishlab chiquvchilar uchun
2 ta ish
Ish: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia